{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:25:59Z","timestamp":1790331959634,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,2,7]],"date-time":"2010-02-07T00:00:00Z","timestamp":1265500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00394-010-0095-x","type":"journal-article","created":{"date-parts":[[2010,2,6]],"date-time":"2010-02-06T07:30:21Z","timestamp":1265441421000},"page":"373-384","source":"Crossref","is-referenced-by-count":19,"title":["In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients"],"prefix":"10.1007","volume":"49","author":[{"given":"Katja","family":"Berginc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"\u017dakelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albin","family":"Kristl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,7]]},"reference":[{"issue":"3S","key":"95_CR1","doi-asserted-by":"crossref","first-page":"951S","DOI":"10.1093\/jn\/131.3.951S","volume":"131","author":"RS Rivlin","year":"2001","unstructured":"Rivlin RS (2001) Historical perspective on the use of garlic. J Nutr 131(3S):951S\u2013954S","journal-title":"J Nutr"},{"key":"95_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1098-1128(199601)16:1<111::AID-MED4>3.0.CO;2-5","volume":"16","author":"KC Agarwal","year":"1996","unstructured":"Agarwal KC (1996) Therapeutic actions of garlic constituents. Med Res Rev 16:111\u2013124","journal-title":"Med Res Rev"},{"key":"95_CR3","first-page":"93","volume":"25","author":"S Ejaz","year":"2003","unstructured":"Ejaz S, Woong LC, Ejaz A (2003) Extract of garlic (Allium Sativum) in cancer chemoprevention. Exp Oncol 25:93\u201397","journal-title":"Exp Oncol"},{"issue":"3S","key":"95_CR4","doi-asserted-by":"crossref","first-page":"989S","DOI":"10.1093\/jn\/131.3.989S","volume":"131","author":"YY Yeh","year":"2001","unstructured":"Yeh YY, Liu L (2001) Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr 131(3S):989S\u2013993S","journal-title":"J Nutr"},{"key":"95_CR5","doi-asserted-by":"crossref","first-page":"716S","DOI":"10.1093\/jn\/136.3.716S","volume":"136","author":"H Amagase","year":"2006","unstructured":"Amagase H (2006) Clarifying the real bioactive constituents of garlic. J Nutr 136:716S\u2013725S","journal-title":"J Nutr"},{"key":"95_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(99)06457-0","volume":"355","author":"A Fugh-Berman","year":"2000","unstructured":"Fugh-Berman A (2000) Herb-drug interactions. Lancet 355:134\u2013138","journal-title":"Lancet"},{"key":"95_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","volume":"22","author":"CY Wu","year":"2005","unstructured":"Wu CY, Benet LZ (2005) Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutical drug disposition classification system. Pharm Res 22:11\u201323","journal-title":"Pharm Res"},{"key":"95_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1211\/002235702603","volume":"55","author":"S Deferme","year":"2003","unstructured":"Deferme S, Augustijns P (2003) The effect of food components on the absorption of Pgp substrates: a review. J Pharm Pharmacol 55:153\u2013162","journal-title":"J Pharm Pharmacol"},{"key":"95_CR9","first-page":"176","volume":"4","author":"B Foster","year":"2001","unstructured":"Foster B, Foster M, Vandenhoek S, Krantis A, Budzinski JW, Arnason JT, Gallicano KD, Choudri S (2001) An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharmaceut Sci 4:176\u2013184","journal-title":"J Pharm Pharmaceut Sci"},{"key":"95_CR10","first-page":"34","volume-title":"Onions and allied crops: food science and minor crops","author":"JE Lancaster","year":"1989","unstructured":"Lancaster JE, Boland MJ (1989) Flavor Biochem. In: Brewster JL, Rabinowitch HD (eds) Onions and allied crops: food science and minor crops. CRC Press, USA, pp 34\u201354"},{"key":"95_CR11","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/jxb\/erh138","volume":"55","author":"MG Jones","year":"2004","unstructured":"Jones MG, Hughes J, Tregova A, Milne J, Tomsett AB, Collin HA (2004) Biosynthesis of the flavour precursors of onion and garlic. J Exp Bot 55:1903\u20131918","journal-title":"J Exp Bot"},{"key":"95_CR12","first-page":"214","volume-title":"Functional foods, biochemical and processing aspects","author":"BJ Holub","year":"2002","unstructured":"Holub BJ, Arnott K, Davis JP, Nagpurkar A, Peschell J (2002) Organosulfur compounds from garlic. In: Shi J, Mazza G, Maguer M (eds) Functional foods, biochemical and processing aspects. CRC Press, USA, pp 214\u2013231"},{"key":"95_CR13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1248\/bpb.32.694","volume":"32","author":"K Berginc","year":"2009","unstructured":"Berginc K, Ur\u0161i\u010d D, \u017dakelj S, Kristl A (2009) Aged garlic extract stimulates P-glycoprotein and multidrug resistance associated protein 2 mediated effluxes. Biol Pharm Bull 32:694\u2013699","journal-title":"Biol Pharm Bull"},{"issue":"3S","key":"95_CR14","doi-asserted-by":"crossref","first-page":"968S","DOI":"10.1093\/jn\/131.3.968S","volume":"131","author":"RT Rosen","year":"2001","unstructured":"Rosen RT, Hiserodt RD, Fukuda EK, Ruiz RJ, Zhou Z, Lech J, Rosen SL, Hartman TG (2001) Determination of allicin, S-allylcysteine and volatile metabolites of garlic in breath, plasma or simulated gastric fluids. J Nutr 131(3S):968S\u2013971S","journal-title":"J Nutr"},{"issue":"S3","key":"95_CR15","doi-asserted-by":"crossref","first-page":"955S","DOI":"10.1093\/jn\/131.3.955S","volume":"131","author":"H Amagase","year":"2001","unstructured":"Amagase H, Petesch BL, Matsuura H, Kasuga S (2001) Intake of garlic and its bioactive components. J Nutr 131(S3):955S\u2013962S","journal-title":"J Nutr"},{"key":"95_CR16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","volume":"250","author":"AB Shapiro","year":"1997","unstructured":"Shapiro AB, Ling V (1997) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem 250:130\u2013137","journal-title":"Eur J Biochem"},{"key":"95_CR17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1177\/00912709922012006","volume":"39","author":"DK Yu","year":"1999","unstructured":"Yu DK (1999) The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions. J Clin Pharmacol 39:1203\u20131211","journal-title":"J Clin Pharmacol"},{"key":"95_CR18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1023\/A:1020444330011","volume":"19","author":"YH Zhao","year":"2002","unstructured":"Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I (2002) Rate-limiting steps of human oral absorption and QSAR studies. Pharm Res 19:1446\u20131457","journal-title":"Pharm Res"},{"key":"95_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0090-9556(25)07290-3","volume":"24","author":"SF Su","year":"1996","unstructured":"Su SF, Huang JD (1996) Inhibition of intestinal digoxin absorption and exsorption by quinidine. Drug Metab Dispos 24:142\u2013147","journal-title":"Drug Metab Dispos"},{"key":"95_CR20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/sj.bjp.0703150","volume":"129","author":"A Soldner","year":"2000","unstructured":"Soldner A, Benet LZ, Mutschler E, Christians U (2000) Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers. Br J Pharmacol 129:1235\u20131243","journal-title":"Br J Pharmacol"},{"key":"95_CR21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/dmd.105.008938","volume":"34","author":"W Yamashiro","year":"2006","unstructured":"Yamashiro W, Maeda K, Hirouchi M, Adachi Y, Hu Z, Sugiyama Y (2006) Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptors in humans. Drug Metab Dispos 34:1247\u20131254","journal-title":"Drug Metab Dispos"},{"key":"95_CR22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/mol.57.4.760","volume":"57","author":"E Bakos","year":"2000","unstructured":"Bakos E, Evers R, Sinko E, Varadi A, Borst P, Sarkadi B (2000) Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol 57:760\u2013768","journal-title":"Mol Pharmacol"},{"key":"95_CR23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1023\/A:1011036428972","volume":"18","author":"E Wang","year":"2001","unstructured":"Wang E, Casciano CN, Clement RP, Johnson WW (2001) HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein. Pharm Res 18:800\u2013806","journal-title":"Pharm Res"},{"key":"95_CR24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp0499196","volume":"2","author":"MVS Varma","year":"2004","unstructured":"Varma MVS, Sateesh K, Panchagnula R (2004) Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport. Mol Pharm 2:12\u201321","journal-title":"Mol Pharm"},{"key":"95_CR25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.106.101840","volume":"319","author":"MJ Zamek-Gliszczynski","year":"2006","unstructured":"Zamek-Gliszczynski MJ, Hoffmaster KA, Humphreys JE, Tian X, Nezasa K, Brouwer KLR (2006) Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulphate in the rat. JPET 319:459\u2013467","journal-title":"JPET"},{"key":"95_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2006.02.004","volume":"313","author":"S \u017dakelj","year":"2006","unstructured":"\u017dakelj S, \u0160turm K, Kristl A (2006) Ciprofloxacin permeability and its active secretion through rat small intestine in vitro. Int J Pharm 313:175\u2013180","journal-title":"Int J Pharm"},{"key":"95_CR27","unstructured":"Guidance for industry bioavailability and bioequivalence studies for orally administered drug products \u2014 general considerations. Food and Drug Administration, Center for Drug evaluation and Research (CDER). Available via DIALOG http:\/\/www.fda.gov\/cder\/guidance\/index.htm"},{"key":"95_CR28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/dmd.108.020859","volume":"36","author":"C Maclean","year":"2008","unstructured":"Maclean C, Moenning U, Reichel A, Fricker G (2008) Closing the gaps\u2013A full scan of the intestinal expression of Pgp, Bcrp and Mrp2 in male and female rats. Drug Metab Dispos 36:1249\u20131254","journal-title":"Drug Metab Dispos"},{"key":"95_CR29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clpt.2005.06.013","volume":"78","author":"E Lee","year":"2005","unstructured":"Lee E, Ryan S, Birmingam B, Zalikowski J, March R, Ambrose H, Moore R, Lee C, Chen Y (2005) Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther 78:330\u2013341","journal-title":"Clin Pharmacol Ther"},{"key":"95_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejps.2003.10.010","volume":"21","author":"B Steffansen","year":"2004","unstructured":"Steffansen B, Nielsen CU, Brodin B, Eriksson AH, Andersen R, Frokjaer S (2004) Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption. Eur J Pharm Sci 21:3\u201316","journal-title":"Eur J Pharm Sci"},{"key":"95_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/mp034001k","volume":"1","author":"TN Faria","year":"2003","unstructured":"Faria TN, Timoszyk JK, Stouch TR, Vig BS, Landowski CP, Amidon GL, Weaver CD, Wall DA, Smith RL (2003) A novel high-throughput Pept1 transporter assay differentiates between substrates and antagonists. Mol Pharm 1:67\u201376","journal-title":"Mol Pharm"},{"key":"95_CR32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11095-006-9159-2","volume":"24","author":"KT Kivist\u00f6","year":"2007","unstructured":"Kivist\u00f6 KT, Niemi M (2007) Influence of drug transporter polimorphism on pravastatin pharmacokinetics in humans. Pharm Res 24:239\u2013247","journal-title":"Pharm Res"},{"key":"95_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2133\/dmpk.18.1","volume":"18","author":"T Katsura","year":"2003","unstructured":"Katsura T, Inui KI (2003) Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation. Drug Metab Pharmacokinet 18:1\u201315","journal-title":"Drug Metab Pharmacokinet"},{"key":"95_CR34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejps.2005.01.001","volume":"24","author":"X Sha","year":"2005","unstructured":"Sha X, Yan G, Wu Y, Li J, Fang X (2005) Effect of self-emulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci 24:477\u2013486","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"95_CR35","doi-asserted-by":"crossref","first-page":"736S","DOI":"10.1093\/jn\/136.3.736S","volume":"136","author":"K Rahman","year":"2006","unstructured":"Rahman K, Lowe GM (2006) Garlic and cardiovascular disease: a critical review. J Nutr 136(3):736S\u2013740S","journal-title":"J Nutr"},{"key":"95_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s002280050259","volume":"52","author":"G Flesch","year":"1997","unstructured":"Flesch G, Muller PL (1997) Absolute bioavailability and pharmacokinetics of valsaratn, an angiotensin II receptor antagonist, in man. Eur J Clin Pharmacol 52:115\u2013120","journal-title":"Eur J Clin Pharmacol"},{"key":"95_CR37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0009-9236(95)90020-9","volume":"58","author":"MW Lo","year":"1995","unstructured":"Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek C, Bjornsson TD (1995) Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clin Pharmacol Ther 58:641\u2013649","journal-title":"Clin Pharmacol Ther"},{"key":"95_CR38","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/carcin\/bgi139","volume":"26","author":"B Ebert","year":"2005","unstructured":"Ebert B, Seidel A, Lampen A (2005) Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26:1754\u20131763","journal-title":"Carcinogenesis"},{"key":"95_CR39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389200043489199","volume":"5","author":"A Heimeur","year":"2004","unstructured":"Heimeur A, Conseil G, Deeley RG, Cole SPC (2004) The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Current drug metabolism 5:21\u201353","journal-title":"Current drug metabolism"},{"key":"95_CR40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/dmd.105.007534","volume":"34","author":"L Huang","year":"2006","unstructured":"Huang L, Wang Y, Grimm S (2006) ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein. Drug Metab Dispos 34:738\u2013743","journal-title":"Drug Metab Dispos"},{"key":"95_CR41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0223-5234(03)00100-4","volume":"38","author":"B Masereel","year":"2003","unstructured":"Masereel B, Pochet L, Laeckmann D (2003) An overview of inhibitors of Na\/H exchanger. Eur J Med Chem 38:547\u2013554","journal-title":"Eur J Med Chem"},{"key":"95_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0928-0987(03)00169-6","volume":"21","author":"P Anderle","year":"2004","unstructured":"Anderle P, Huang Y, Sadee W (2004) Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays. Eur J Pharm Sci 21:17\u201324","journal-title":"Eur J Pharm Sci"},{"key":"95_CR43","first-page":"571","volume":"343","author":"N Gupta","year":"2006","unstructured":"Gupta N, Martin PM, Miyauchi S, Ananth S, Herdman AV, Martindale RG, Podolsky R, Ganapathy V (2006) Down-regulation of BCRP\/ABCG2 in colorectal and cervical cancer. BBRC 343:571\u2013577","journal-title":"BBRC"},{"key":"95_CR44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2006.04.005","volume":"320","author":"HS Shin","year":"2006","unstructured":"Shin HS, Bae SK, Lee MG (2006) Pharmacokinetics of sildenafil after intravenous and oral administration of rats: hepatic and intestinal first-pass effects. Int J Pharm 320:64\u201370","journal-title":"Int J Pharm"},{"issue":"5","key":"95_CR45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00424-003-1067-2","volume":"447","author":"AP Halestrap","year":"2004","unstructured":"Halestrap AP, Meredith D (2004) The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447(5):619\u2013628","journal-title":"Pflugers Arch"},{"key":"95_CR46","doi-asserted-by":"crossref","first-page":"C846","DOI":"10.1152\/ajpcell.00112.2005","volume":"289","author":"RK Gill","year":"2005","unstructured":"Gill RK, Saksena S, Alrefai WA, Sarwar Z, Goldstein JL, Carroll RE, Ramaswamy K, Dudeja PK (2005) Expression and membrane localization of MCT isoforms along the length of human intestine. Am J Physiol Cell Physiol 289:C846\u2013C852","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-010-0095-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-010-0095-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-010-0095-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T20:18:15Z","timestamp":1739823495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-010-0095-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,7]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["95"],"URL":"https:\/\/doi.org\/10.1007\/s00394-010-0095-x","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,7]]}}}